Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

VJOncology

- PMLiVE

Johnson & Johnson to acquire Alios BioPharma for $1.75bn

Will gain access to the biopharma's portfolio of viral infection candidates

- PMLiVE

Cancer pain: opioids set to dominate

But much work is being done to improve the delivery systems of these drugs

- PMLiVE

Good practice in blood clot care recognised at awards

First winners of QiC Anticoagulation programme announced

- PMLiVE

EMA to review experimental Ebola drugs

Response comes as death-toll tops 3,000

- PMLiVE

PD1 drugs could end ‘decades of silence’ in bladder cancer therapy

Merck's Keytruda and Roche antibody showing promise

- PMLiVE

Janssen, AZ and Roche at ESMO

Companies present promising data on new cancer drugs

- PMLiVE

Amag buys into maternal health business

Will acquire female health specialist Lumara Health

- PMLiVE

Alacrita appoints Stuart Hendry as associate partner

Joins from medical device firm Sphere Medical

Daiichi Sankyo logo

Japan’s Daiichi Sankyo pays $410m for Ambit Biosciences

Gains rights to cancer drug quizartinib

- PMLiVE

EMA wants to embed patient viewpoint within drug assessment

Will pilot CHMP benefit-risk evaluation project

Gilead Sciences

Gilead’s hep C combination Harvoni recommended for EU approval

CHMP backs combination of Sovaldi and ledipasvir

- PMLiVE

Virgo Health names US head

Nancy Caravetta to lead the UK comms agency's new PR practice in New York

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links